Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,288 across all filing types
Latest filing 2020-07-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
关于控股公司使用部分暂时闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Changchun High-tech Industry Group Co., Ltd. regarding the progress of its controlling company's use of temporarily idle funds to purchase financial products. It details the types of financial products purchased, amounts, dates, risk disclosures, and risk control measures. The document is an announcement about financing activities related to the company's capital management and investment in financial products, not a full financial report or earnings release. It does not contain comprehensive financial statements or detailed financial performance data. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about financing activities, not just a brief notice or regulatory filing. Confidence is high due to clear content focus on capital use and investment products.
2020-07-10 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes and issuance of a new business license. It mentions changes in registered capital and share count following shareholder meeting approvals and board resolutions. The document references other announcements for detailed resolutions and profit distribution but itself is a formal notice of administrative changes. It does not contain financial statements, audit information, or detailed financial results. The document length is short (825 characters) and it is an official announcement of a corporate registration update rather than a report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-07-09 Chinese
关于使用部分暂时闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Changchun High-tech Industry (Group) Co., Ltd. regarding the progress of using temporarily idle self-owned funds to purchase wealth management products. It details the purchase of bank financial products, risk disclosures, risk control measures, and the impact on daily operations. The document is a formal public announcement about the company's financing activities related to cash management and investment in financial products. It does not contain financial statements, earnings data, or detailed management analysis. It is not a report itself but an update on capital usage and investment activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5500 characters, which is sufficient for a detailed announcement but not a full financial report.
2020-07-08 Chinese
关于儿童药平台项目的对外投资公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an external investment by Changchun High-tech Industry (Group) Co., Ltd. It details the company's subscription to preferred shares of a US company, Brillian Pharma Inc., including the investment amount, shareholding structure before and after the investment, and the purpose and risks of the investment. There are no financial statements or comprehensive financial performance data presented. The document is a formal disclosure of a capital investment transaction, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it provides information on a financing activity and capital structure change through investment in another company.
2020-07-07 Chinese
第九届董事会第二十七次会议决议公告
Board/Management Information Classification · 100% confidence The document is a board meeting resolution announcement from Changchun High-tech Industry (Group) Co., Ltd. It details the convening of the 27th meeting of the 9th board of directors, the approval of an investment in preferred shares of a US company, and the authorization for subsequent agreement signings. The document includes voting results and mentions the presence of independent directors' opinions. It does not contain financial statements or detailed financial data but is an official announcement of a board decision. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1322 characters), and it is not a report or financial statement but a formal board resolution announcement.
2020-07-07 Chinese
独立董事关于第九届董事会第二十七次会议审议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters reviewed at the 27th meeting of the 9th board of directors of Changchun High-tech Industry (Group) Co., Ltd. It discusses the legality and appropriateness of an investment decision, referencing compliance with stock exchange listing rules and company articles. The document is a formal statement related to board meeting deliberations, not a full annual or interim report, audit report, or earnings release. It is not a call transcript, capital update, or voting result announcement. The content fits best under Board/Management Information (MANG) as it relates to board decisions and management oversight.
2020-07-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.